Funded Tech Companies
ReCode Therapeutics
Headquartered in Menlo Park, ReCode Therapeutics is venture-backed, with investment from Amgen Ventures, Pfizer Venture Investments and Leaps by Bayer.
Company Overview
Company Name
ReCode Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1455 Adams Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Company Background Information
Overview
ReCode Therapeutics is a biopharmaceutical company developing precision medicines for pulmonary diseases with significant unmet medical need. ReCode's diverse pipeline includes lead programs for primary ciliary dyskinesia (PCD) and nonsense mutations in cystic fibrosis (CF).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/19/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Lockhart
Company Investors
- Amgen Ventures
- Pfizer Venture Investments (Rana Al-Hallaq)
- Leaps by Bayer (Juergen Eckhardt)
- OrbiMed (Peter Thompson)
- Osage University Partners
- Sanofi Ventures
- Bioluminescence Ventures (Kouki Harasaki)
- EcoR1 Capital Management (Oleg Nodelman)
- Solasta Ventures
- MPM Capital (Ed Hurwitz)
- Vida Ventures (Helen Kim)
- Matrix Capital Management
- Sanofi-Genzyme BioVentures
- Superstring Capital
- NS Investment
- Osage Partners
- Colt Ventures
- Hunt Technology Ventures
Browse more funded tech companies:
Share this article
About Our VC Deals Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs